Simplicity Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Simplicity Wealth's BMY Position: Q2 2026 in Review
Simplicity Wealth increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2026, buying an estimated $41.6K and bringing the position to 12,229 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #531.
Simplicity Wealth first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.43M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Simplicity Wealth held 12,229 shares of Bristol-Myers Squibb worth $705K as of Q2 2026.
- Simplicity Wealth bought 725 Bristol-Myers Squibb shares in Q2 2026, an estimated $41.6K.
- Bristol-Myers Squibb made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #531 holding.
- Simplicity Wealth first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
- Simplicity Wealth's Bristol-Myers Squibb position peaked at $3.43M in Q1 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.